FDA Warns Total Thermal Imaging for Unapproved Screening Device

The GMP Letter
A A
The FDA warned La Mesa, California-based devicemaker Total Thermal Imaging for marketing an unapproved device for breast cancer screening.

To View This Article:

Login

Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $40.00